ULTRAGENYX PHARMACEUTICAL INC. (RARE)

SEC filing

ULTRAGENYX PHARMACEUTICAL INC.

RARE · CIK 1515673

4 · Sep 8, 2026 · SVP, Chief Accounting Officer Huizenga Theodore Alan sold 161 shares at $13.99/share ($2,252)

SVP, Chief Accounting Officer Huizenga Theodore Alan sold 161 shares at $13.99/share ($2,252)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).